Research Article

Prevalence and Factors Associated with Rifampicin Resistant Pulmonary Tuberculosis among Presumptive Patients in Kano State, Nigeria

1 North West Zonal Tuberculosis Reference Laboratory, Department of Medical Microbiology, Aminu Kano Teaching Hospital, Kano, Nigeria.
2 Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna
3 National Tuberculosis and Leprosy Training Centre, Saye, Zaria, Kaduna State, Nigeria.
4 Nigeria Field Epidemiology and Laboratory Training Programme, African Field Epidemiology Network, Abuja, Nigeria.
5 Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University Kano, P.M.B. 3011.
6 Infectious Disease Hospital, Ministry of Health, Kano, Kano State, Nigeria.
7 Department of Biological Sciences School of Pure and Applied Sciences, Mount Kenya University, Thika, Kenya.
8 Department of Microbiology, Faculty of Life Sciences, Bayero University, Kano Nigeria.
9 Department of Science Laboratory Technology, School of Technology, Kano state polytechnic, Matan-fada Road, PMB 3348, Kano State, Nigeria
* Corresponding author: mohammadab@nsmjournal.org.ng
Published: Jun, 2021
Pages: 5460-5466

Abstract

Rifampicin-resistant tuberculosis (TB) is an emerging problem of great importance to public  health worldwide and together with multidrug-resistant TB causes higher mortality rates than drug sensitive tuberculosis. Data regarding drug-resistance and risk factors associated with rifampicin resistant  from Kano are lacking. The study therefore, determined the prevalence and risk factors associated with  rifampicin-resistant tuberculosis (RR-TB) in Kano State, Nigeria. A one-year retrospective study was  conducted among tuberculosis patients attending Direct Observed Treatment Short-course centers  equipped with GeneXpert facilities in Kano State, Nigeria from January 2019 to December, 2019.  Pulmonary and extra-pulmonary samples were analyzed using Xpert MTB/RIF assay (Cepheid,  GeneXpert, USA). The data was collected from the Xpert MTB/RIF assay registers and patient’s folder.  Data generated were analyzed using Chi-square and results were presented in tables. Out of 55,021  samples analyzed, 111 (0.2%) had rifampicin-resistant tuberculosis. There was significance relationship  between socio-demographic characteristics (gender, age groups and marital status), prevalence and  transmission dynamic of rifampicin resistant among the studied subject in the study area (Odds Ratio [OR]  = 0.37, 2.54, 1.51; p≤0.5). The study confirmed the presence of rifampicin resistant tuberculosis in the  study area. It also identifies the need to strengthen the laboratory capacity for early diagnosis of RR-TB as  well as improvement on availability and accessibility of the services to patients by the relevant authorities  to reduce the disease burden.
   
How to Cite

A.B, M., A., I., I, M. A., S, B. M., Y., M., S, F. H., S, I., I., A. A., & M.D., M. (2021). Prevalence and Factors Associated with Rifampicin Resistant Pulmonary Tuberculosis among Presumptive Patients in Kano State, Nigeria. Nigerian Journal of Microbiology, 35(1), 5460-5466.

M. A.B, I. A., M. A. I, B. M. S, M. Y., F. H. S, I. S, A. A. I., and M. M.D., "Prevalence and Factors Associated with Rifampicin Resistant Pulmonary Tuberculosis among Presumptive Patients in Kano State, Nigeria," Nigerian Journal of Microbiology, vol. 35, no. 1, pp. 5460-5466, June 2021.

Share this article:
Facebook X / Twitter LinkedIn